Megan A. Marlow-O'Connor, Ph.D.
Affiliations: | 2005 | Rosalind Franklin University of Medicine and Science, North Chicago, IL, United States |
Area:
Clinical Psychology, Mental HealthGoogle:
"Megan Marlow-O'Connor"Mean distance: 19.12 (cluster 50)
Parents
Sign in to add mentorRoland J. Erwin | grad student | 2005 | Rosalind Franklin Medical School | |
(fMRI indices of frontal activation associated with sensory gating deficits in schizophrenia.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Goldman MB, Wang L, Wachi C, et al. (2011) Structural pathology underlying neuroendocrine dysfunction in schizophrenia. Behavioural Brain Research. 218: 106-13 |
Torres IJ, Keedy S, Marlow-O'Connor M, et al. (2009) Neuropsychological impairment in patients with schizophrenia and evidence of hyponatremia and polydipsia. Neuropsychology. 23: 307-14 |
Schirmer TN, Dorflinger JM, Marlow-O'Connor M, et al. (2009) FMRI indices of auditory attention in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 25-32 |
Goldman M, Marlow-O'Connor M, Torres I, et al. (2008) Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophrenia Research. 98: 247-55 |
Goldman MB, Torres IJ, Keedy S, et al. (2007) Reduced anterior hippocampal formation volume in hyponatremic schizophrenic patients. Hippocampus. 17: 554-62 |
Keedy SK, Marlow-O'Connor M, Beenken B, et al. (2007) Noradrenergic antagonism of the P13 and N40 components of the rat auditory evoked potential. Psychopharmacology. 190: 117-25 |
Keedy S, Torres I, Marlow-O'Connor M, et al. (2003) Amygdala structure and associated neuropsychological function in schizophrenia Schizophrenia Research. 60: 140-141 |